Question 1

Ingredient Compatibility: 7 Powerful Checks to Prevent Costly Formulation Problems

Accepted Answer

Home > Blog
Ingredient Compatibility: 7 Powerful Checks to Prevent Costly Formulation Problems
Ingredient Compatibility is often overlooked when every individual raw material already meets its own specification.
A botanical extract passes testing. An amino acid meets its purity requirement. A probiotic ingredient shows the expected viable count. A functional powder has acceptable moisture and particle size.
Then the ingredients are combined into one formulation—and something changes.
The powder starts absorbing moisture and forming lumps. The color gradually changes. The blend separates during handling. Solubility becomes inconsistent. An active ingredient loses stability during storage. A formulation that looked perfectly acceptable on paper becomes difficult to manufacture.
This is one of the less obvious challenges in multi-ingredient product development: individual raw-material quality does not automatically mean formulation compatibility.
																														
Why Ingredient Compatibility Is Different From Raw Material Quality
A raw material is normally evaluated against its own specification.
That specification may include identity, assay, moisture, microbiological limits, particle size, heavy metals, residual solvents, or other parameters relevant to the material.
But a formulation creates a new environment.
Once several ingredients are combined, their physical and chemical properties can influence each other. Moisture can move between components. Different particle sizes can affect blend uniformity. Differences in density or flowability can cause segregation. A change in pH may affect another ingredient&#8217;s stability. Temperature, humidity, oxygen exposure, processing conditions, and packaging can further change the behavior of the finished blend.
This means a COA can confirm what an ingredient is and whether it meets its specification, but it cannot by itself prove that the ingredient will perform well inside every formulation.
That distinction is critical for developers working with probiotics, botanical extracts, amino acids, vitamins, minerals, functional powders, and multi-ingredient blends.
1. Check Moisture Sensitivity Before Combining Ingredients
Moisture is one of the most common sources of formulation problems.
Two powders may each meet their individual moisture specifications but behave differently when stored together.
For example, one ingredient may be relatively hygroscopic while another is sensitive to moisture. If the first ingredient absorbs water from the surrounding environment, it can change the local moisture conditions of the blend. The result may be caking, reduced flowability, changes in powder structure, or accelerated degradation of a moisture-sensitive component.
Water activity can also become relevant when the formulation contains ingredients with different moisture-management requirements.
This is why simply comparing the moisture values on individual COAs is not always enough.
For moisture-sensitive formulations, procurement and R&D teams should consider:

Moisture content
Water activity where relevant
Hygroscopicity
Recommended storage conditions
Packaging requirements
Expected exposure during manufacturing and transport

The question is not simply, “Does this ingredient have acceptable moisture?”
It is, “What happens when this ingredient shares the same formulation environment with the other components?”
2. Compare Particle Size, Density, and Powder Behavior
A blend can be chemically acceptable and still fail physically.
Particle size is particularly important for powders. When ingredients have substantially different particle-size distributions, shapes, densities, or flow properties, they may not remain uniformly distributed during mixing, transfer, filling, or transportation.
Powder segregation can occur through mechanisms such as sifting, rolling, or air entrainment. Research in pharmaceutical powder systems has shown that particle-size differences, density differences, powder flow properties, and equipment conditions can all contribute to segregation.
This matters well beyond tablets.
The same principle can affect:

Powder sachets
Capsules
Stick packs
Premixes
Functional food powders
Supplement blends
Granulated products

A specification that says “powder” is therefore incomplete for many applications.
Depending on the formulation, it may be useful to compare particle-size distribution, mesh range, bulk density, tapped density, flow characteristics, and morphology across the major ingredients.
The objective is not necessarily to make every ingredient identical.
The objective is to understand whether their physical differences create a practical risk to blend uniformity.
3. Look for pH and Chemical Interaction Risks
Some compatibility problems are physical. Others are chemical.
An ingredient may be stable within a particular pH range but less stable outside it. Another component may change the local environment of the formulation after dissolution or during processing.
This can become important in liquid formulations, effervescent products, beverages, gummies, powders intended for reconstitution, and other systems where ingredients interact with water.
Potential questions include:

Does one ingredient significantly change the pH?
Could an acidic component affect another active?
Are oxidation-sensitive ingredients present?
Could minerals interact with other components?
Does the formulation contain reducing or oxidizing substances?
Are heat or water introduced during processing?

Not every combination will create a meaningful reaction, but the risk should be considered when the chemistry of the ingredients suggests a potential interaction.
4. Evaluate Stability Under the Actual Formulation Conditions
An ingredient can be stable by itself but less stable after formulation.
For example, an active may remain acceptable under its recommended storage condition when packaged alone. Once combined with other ingredients, however, the formulation may have a different moisture environment, oxygen exposure, pH, physical structure, or microenvironment.
Stability therefore needs to be considered in context.
For products where stability is critical, development teams should evaluate relevant conditions such as:

Temperature
Relative humidity
Light exposure
Oxygen exposure
Packaging configuration
Storage duration
Transportation conditions

Stability guidance commonly emphasizes evaluating the product under defined environmental conditions and considering the packaging system rather than treating stability as a single fixed property.
The exact study design depends on the product and market. The important point is that formulation stability should be evaluated on the actual formulation—not assumed from the individual ingredients.
																														
5. Check Solubility and Dispersion Together
Solubility is another area where individual specifications can be misleading.
Two ingredients may each have acceptable solubility characteristics but behave differently when placed into the same system.
One component may dissolve quickly while another disperses slowly. A high concentration of one ingredient may alter the solution environment. Certain powders may form aggregates or sediment during reconstitution.
This is particularly important for:

Powdered beverages
Instant drinks
Liquid supplements
Water-soluble blends
Effervescent formulations
Functional drink mixes

Instead of asking only whether an ingredient is “water soluble,” it is often more useful to ask how it behaves under the actual formulation conditions.
Temperature, concentration, pH, mixing sequence, particle size, and the presence of other ingredients can all affect the final result.
6. Review the Manufacturing Process, Not Just the Formula
Ingredient compatibility does not stop at the formulation sheet.
The manufacturing process can introduce additional stress.
High-speed mixing, milling, granulation, compression, heat, moisture addition, long residence times, and repeated powder transfer can change how ingredients behave.
A blend that looks uniform immediately after mixing may segregate during transfer or filling. Conversely, a formulation that appears difficult to blend initially may become more stable after granulation or another processing step.
This is why formulation development should connect three elements:
Ingredient properties → processing conditions → finished-product performance.
Changing any one of these can change the overall behavior.
For procurement teams, this also means that “standard grade” is not always enough information. A particular particle size, density, solubility profile, or physical form may be more suitable for one manufacturing process than another.
7. Compare the Approved Sample With the Commercial Batch
One of the most practical Ingredient Compatibility checks happens before scale-up.
A development sample may perform well because its physical properties happen to fit the formulation.
But if the commercial batch has noticeably different particle size, bulk density, moisture, color, flowability, or other relevant characteristics, the formulation may behave differently.
This is why sample approval should not automatically mean the sourcing process is finished.
Before commercial production, it is useful to confirm:

The commercial specification
Key physical parameters
Manufacturing or processing characteristics where relevant
Packaging
Storage conditions
COA requirements
Batch-to-batch consistency
Any critical attributes identified during formulation testing

The goal is not to freeze every parameter unnecessarily.
The goal is to identify the parameters that actually matter to the formulation and control them consistently.
A Better Way to Think About Ingredient Compatibility
Ingredient Compatibility should not be treated as a simple pass-or-fail property attached to a raw material.
It is better understood as a relationship between:
Ingredient properties + formulation composition + processing + packaging + storage conditions.
This explains why the same ingredient can work extremely well in one product and create problems in another.
A botanical extract may be suitable for a capsule but require different specifications for a powdered beverage.
An amino acid with excellent purity may still need a particular particle-size range for a specific powder blend.
A probiotic ingredient may require tighter attention to moisture exposure and packaging than another functional ingredient.
The raw material itself has not necessarily changed.
The application has.
																														
What Procurement Should Ask Before Buying
For a multi-ingredient formulation, procurement does not need to become the formulation scientist.
But procurement can ask better questions before placing the order.
Instead of asking only:
“What is the price per kilogram?”
consider asking:
“What specification is appropriate for this application?”
Useful information may include:

Intended dosage form
Target particle size
Solubility requirement
Moisture or water activity sensitivity
Bulk density requirements
Storage conditions
Packaging format
Required certifications or documentation
Expected annual volume
Sample-to-commercial batch consistency

This creates a much stronger connection between R&D requirements and sourcing decisions.
From Raw Material Sourcing to Application-Fit Sourcing
The purpose of sourcing is not simply to find an ingredient that passes a COA.
The more useful objective is to find an ingredient that fits the intended application and can remain consistent as the project moves from laboratory testing to commercial production.
At Esubio, we approach ingredient sourcing from the application side first.
For botanical extracts, amino acids, probiotics, postbiotics, fruit and vegetable powders, and functional blends, we discuss relevant requirements such as specification, particle size, solubility, storage conditions, documentation, and intended use before matching a suitable supply option.
We provide COA, MSDS, and product specifications with shipments as applicable.
This does not replace formulation compatibility testing. Final compatibility still needs to be verified within the customer&#8217;s own formulation, process, packaging, and storage conditions.
But understanding the application before sourcing can help identify obvious risks earlier—before they become expensive formulation problems.
The Bottom Line
A formulation can fail even when every individual raw material passes its own quality test.
That is because Ingredient Compatibility is not the same as individual ingredient quality.
Moisture sensitivity, particle size, density, solubility, pH, processing conditions, packaging, and batch consistency can all influence how multiple ingredients behave together.
For R&D teams, the lesson is to test the actual formulation environment.
For procurement teams, the lesson is to communicate the application before selecting the specification.
And for both, the goal is the same:
Do not buy a raw material only because it is qualified on paper. Make sure its critical properties make sense for the formulation in which it will actually be used.
References

ICH Q1A(R2) Stability Testing of New Drug Substances and Products
PMC: Blend Segregation in Tablets Manufacturing and Its Effect on Drug Content Uniformity
PMC: Batch versus Continuous Blending of Binary and Ternary Pharmaceutical Powder Mixtures

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 2

Capsule and Granulation Sourcing: 7 Smart Checks Before Scale-Up

Accepted Answer

Home > Blog
Capsule and Granulation Sourcing: 7 Smart Checks Before Scale-Up
Capsule and granulation sourcing is often treated as a final procurement step after the formulation has already been approved.
That can create problems.
A formulation may look complete on paper, with the active ingredients, excipients and target dosage already defined. But when the project moves toward pilot production or scale-up, the team may discover that the powder does not flow consistently, the target fill weight is difficult to achieve, the selected capsule shell does not fit the intended market, or the formulation needs granulation before it can run reliably on the production line.
At that point, the problem is no longer simply formulation development. It becomes a dosage-form and sourcing problem.
Capsule filling performance is strongly influenced by powder properties. Research has shown that powder flow characteristics can significantly affect capsule fill weight and weight variability, while particle size, density, cohesion and compressibility can all influence filling behavior. 
This is why capsule shells and granulation should be considered earlier in the development process rather than left until the final purchasing stage.
																														
Capsule and Granulation Sourcing Starts with the Dosage Form
Before selecting a capsule supplier or granulation process, the intended dosage form should be clearly defined.
For a capsule project, this may include:

Hard capsule or another capsule format
Gelatin or vegetarian capsule shell
Target capsule size
Target fill weight
Powder or granulated fill
Color and appearance requirements
Printing or branding requirements
Market-specific requirements

Hard gelatin capsule shells, for example, consist primarily of gelatin and water and may contain additional components such as colorants, opacifiers and other processing aids. 
For nutraceutical and functional-ingredient products, vegetarian or plant-based capsule options may also be considered depending on the product positioning and target market.
The important point is that capsule selection should not happen independently from the formulation.
A capsule has a defined physical volume, while the formulation has a defined mass, bulk density and flow behavior. These variables have to work together.
1. Match Capsule Size with the Actual Fill Requirement
One of the most common procurement mistakes is choosing a capsule size based only on the amount of active ingredient.
The actual filling requirement depends on the total formulation weight and the physical characteristics of the blend.
Two formulations containing the same amount of active ingredient can require different capsule sizes because their excipient composition, bulk density, particle size and packing behavior are different.
For this reason, the development team should establish at least:

Total fill weight per capsule
Approximate bulk density
Target capsule size
Expected fill-weight variation
Powder or granule characteristics
Filling equipment or filling method

A theoretical calculation may help with initial screening, but actual filling trials are much more informative.
A formulation that fits within a particular capsule volume on paper may behave differently when it reaches the filling machine.
2. Evaluate Powder Flow Before Blaming the Capsule
When capsule filling becomes inconsistent, the capsule shell is not necessarily the problem.
Powder behavior can be the limiting factor.
Poor flowability may contribute to inconsistent feeding, bridging, segregation, variable fill weights and difficulties during automated filling. Published research has found a significant relationship between powder flow properties and capsule fill weight and weight variability. 
Relevant powder characteristics may include:

Particle size distribution
Bulk density
Tapped density
Compressibility
Cohesion
Particle morphology
Moisture content
Electrostatic behavior
Flowability

This is particularly important when a formulation contains several low-dose active ingredients or fine powders.
A formulation can meet its chemical specifications and still perform poorly during manufacturing because its physical properties are unsuitable for the selected process.
That is why a COA alone may not tell the whole manufacturing story.
3. Decide Whether Granulation Is Actually Necessary
Granulation should not automatically be viewed as an additional processing step.
It should be considered when the powder properties create a practical manufacturing problem that cannot be adequately addressed through formulation adjustment or process optimization.
Granulation can modify particle size, density and flow characteristics. Pharmaceutical literature describes granulation as a process used to improve properties such as flowability, compressibility and the handling of powder blends. 
Depending on the formulation, options may include wet granulation, dry granulation or other particle-engineering approaches.
The choice should depend on the material and the intended process.
For example, a moisture-sensitive formulation may require a different approach from a formulation that can tolerate an aqueous granulation step. Similarly, a formulation containing heat-sensitive components may require careful consideration of processing conditions.
The procurement question therefore should not simply be:
“Can this supplier provide granulation?”
A better question is:
“Which granulation process is suitable for this formulation, and what specifications can the supplier consistently achieve?”
4. Define Granule Specifications Before Ordering
Once granulation becomes part of the project, the granulated material should be treated as a defined intermediate rather than simply “processed powder.”
The specification may need to address:

Particle size distribution
Moisture content
Bulk density
Flowability
Granule strength
Fines content
Appearance
Active content
Content uniformity, where applicable
Storage conditions
Packaging

Particle size is particularly relevant because excessive fines may negatively affect flow, while excessively large or dense granules may behave differently during filling or downstream processing.
Granulation research also shows that changes in excipient composition and processing conditions can affect granule size, density, compressibility and flow behavior. 
This means that a granulation supplier should not be evaluated only by whether it can produce granules. The more important question is whether it can repeatedly produce granules within the required physical and chemical specification.
																														
5. Check Compatibility with the Target Market
Capsule selection can also be influenced by the target market.
For some products, gelatin may be acceptable. For others, the formulation may require a vegetarian or plant-based capsule.
The same applies to certification and market-specific requirements.
Depending on the target market and product positioning, procurement teams may need to confirm requirements related to:

Vegetarian or plant-based status
Halal
Kosher
BSE/TSE documentation, where relevant
Allergen considerations
Colorants
Packaging
Regulatory documentation
Manufacturing-site qualifications

These requirements should be identified before the capsule shell is selected.
Otherwise, the team may complete formulation development with a capsule that later needs to be replaced because it does not satisfy the commercial or market requirements.
That replacement can affect sampling, artwork, packaging specifications and production scheduling.
6. Request Documents for the Capsule Shell and Granulated Material
Capsule shells and granulated intermediates should have their own documentation.
For capsule shells, procurement may need to request:

Product specification
Material composition
Certificate of Analysis
Microbiological specifications
Color specifications
Dimensions and physical specifications
Storage conditions
Relevant certifications
Manufacturing information

For granulated material, the documentation may additionally include:

Granulation process description
Particle size specification
Moisture specification
Bulk density
Active-content testing
Relevant process controls
Batch-specific COA
Shelf-life or storage information

The exact document package will depend on the product, market and manufacturing model.
The objective is to make sure the physical component being purchased can be qualified just as carefully as the active ingredient.
7. Test the Complete System Before Scale-Up
The final and most important check is to evaluate the formulation, capsule shell and filling process as a system.
A good powder may perform differently after blending with other ingredients.
A suitable capsule shell may still be difficult to use if the formulation has poor flow.
A successful laboratory blend may also behave differently during larger-scale filling.
This is why pilot-scale or representative filling trials can be valuable before committing to full production quantities.
The evaluation should consider:

Actual fill weight
Fill-weight variation
Machine performance
Powder feeding
Segregation
Capsule closing
Appearance
Defect rate
Granule behavior
Stability and storage considerations

FDA manufacturing guidance for dosage-form manufacturers also recognizes the need for controls and in-process testing around capsule filling operations. 
The goal is not simply to prove that the capsule can be filled once.
The goal is to establish that the selected formulation and capsule system can be manufactured consistently.
																														
What Should Procurement Ask Before Approving a Capsule or Granulation Supplier?
A practical first-round supplier checklist can include:

What capsule materials and types are available?
Which capsule sizes are suitable for the target fill weight?
Can vegetarian and gelatin options be supplied?
What certifications and quality documents are available?
What are the capsule dimensions and specifications?
Does the formulation require granulation?
If granulation is required, which process is proposed?
What particle size, moisture and bulk-density specifications can be controlled?
Can a representative sample be provided for filling trials?
Can the same specification be maintained during commercial production?

These questions help separate a simple component supplier from a supplier that can support the actual manufacturing requirements of the project.
The Formulation Is Not Finished Until the Dosage Form Works
A formulation is not truly production-ready simply because the ingredient list has been finalized.
The physical behavior of the blend, the capsule specification, the filling process and, where necessary, the granulation process all have to work together.
That is why capsule and granulation sourcing should be considered during formulation development rather than treated as a final purchasing task.
At Esubio, our Capsule Shells & Granulation Solutions are designed to complement functional ingredient sourcing, allowing buyers to evaluate raw materials and dosage-form requirements within the same sourcing process. Depending on the project, this can include capsule shell options, granulation support and relevant product documentation.
For projects that are already technically defined but not yet production-ready, the most useful question may not be:
“Where can we buy the capsule?”
It may be:
“Does the capsule, formulation and powder-processing approach actually work together?”
Answering that question earlier can help reduce last-minute sourcing, formulation changes and avoidable delays during scale-up.
References

Effects of powder flow properties on capsule filling weight uniformity — PubMedhttps://pubmed.ncbi.nlm.nih.gov/23902366/

Comparative evaluation of powder flow parameters with reference to particle size and shape — PubMedhttps://pubmed.ncbi.nlm.nih.gov/29803793/

USP-NF — Hard Gelatin Capsule Shellshttps://doi.org/10.31003/USPNF_M9475_02_01

Granulation techniques and technologies: recent progresses — PMChttps://pmc.ncbi.nlm.nih.gov/articles/PMC4401168/

Advances in Twin-Screw Granulation Processing — PMChttps://pmc.ncbi.nlm.nih.gov/articles/PMC8146340/

FDA — Dosage Form Drug Manufacturers cGMPshttps://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/dosage-form-drug-manufacturers-cgmps-1093

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 3

NMN Ingredient Sourcing: 7 Smart Checks Before You Compare Prices

Accepted Answer

Home > Blog
NMN Ingredient Sourcing: 7 Smart Checks Before You Compare Prices
NMN ingredient sourcing is often approached as a price comparison exercise. A buyer requests several quotations, compares the price per kilogram, checks the stated purity, and then moves to the next step.
For established commodities, this approach may sometimes be practical. For newer ingredients such as NMN and NAD+, however, price alone gives very little information about whether two materials are actually comparable.
The more important questions are: What exactly is being supplied? How is the stated purity measured? Which impurities are controlled? What stability data are available? Can the batch be traced back to its source? And does the supplier have the documentation needed for quality review?
These questions matter because analytical methods, specifications, production processes, storage conditions and documentation can differ between suppliers. Published analytical research on NMN, for example, has used HPLC-based methods to separate NMN from related substances and degradation products, while other recent work has highlighted the importance of distinguishing NMN isomers during analysis. 
																														
For procurement teams evaluating NMN or NAD+ raw materials, the following seven checks can make supplier comparisons much more meaningful.
1. Start with the exact material, not just the product name
“NMN” is a product name, not a complete purchasing specification.
Before requesting a price, define the material as precisely as possible. This may include the chemical name, CAS number, molecular form, physical form, assay requirement, intended application and applicable market requirements.
For NMN, the distinction between different forms or isomers may also be relevant to analytical control. A recent LC-MS/MS study reported substantial variation in isomer composition among commercial NMN supplements, illustrating why identity and analytical specificity should not be treated as secondary details. 
For NAD+, the same principle applies. The buyer should confirm exactly which form is being quoted, including whether the material is supplied as a particular salt, hydrate or other defined form.
A quotation that simply says “NMN 99%” or “NAD+ 98%” is therefore not enough to establish that two suppliers are offering equivalent materials.
2. Ask how purity is measured
The number itself is only part of the specification. The analytical method behind the number is equally important.
When a supplier states “99% purity,” ask:

Which analytical method is used?
Is the result based on HPLC, HPLC-UV, LC-MS or another method?
Is the method validated or otherwise demonstrated to be suitable for the material?
Does the assay distinguish the target compound from related substances?
Is the reported value calculated on an as-is basis or another basis?

This is particularly important for newer ingredients where analytical methods may vary between laboratories.
Research on NMN has demonstrated HPLC methods capable of separating NMN from potential impurities and degradation products. Another study developed an analytical method specifically for assessing NMN-related substances generated during production and storage. 
The practical procurement lesson is simple: do not compare “99% vs. 98%” until you know how both numbers were obtained.
3. Look beyond the headline purity
A high assay result does not automatically describe the complete quality profile of a raw material.
For NMN and NAD+ materials, the specification may also need to address relevant related substances, residual solvents, water content, elemental impurities, microbiological parameters and other product-specific quality attributes.
The exact testing panel should depend on the material, manufacturing process and intended application rather than being copied from another ingredient.
This is where the supplier&#8217;s specification becomes particularly useful. A proper specification should show what is controlled, the acceptance criteria, and where appropriate, the analytical method used.
For example, a supplier may offer a material with a high stated assay but provide little information about related substances or manufacturing-process residues. Another supplier may provide a more complete quality package at a higher price.
The second quotation may therefore represent a materially different level of information rather than simply a more expensive version of the same raw material.
4. Treat stability as part of the specification
Stability should be discussed before purchase rather than after the material arrives.
Temperature, humidity, light, packaging and handling can influence the quality of sensitive ingredients. ICH stability guidance describes stability studies as a way to understand how material quality changes over time under environmental factors such as temperature, humidity and light, and to support appropriate storage conditions and shelf-life or re-test periods. 
NMN research has also investigated degradation under different conditions, with temperature and pH identified as important factors in aqueous systems. 
For procurement, this means asking practical questions:

What is the recommended storage temperature?
Is moisture protection required?
What packaging is used?
What shelf life or re-test period is supported?
Is real-time stability data available?
Is accelerated stability data available?
Are there known sensitivity issues during transportation?

A supplier that cannot clearly explain how the material should be stored may create additional risk even if the initial COA looks acceptable.
																														
5. Review the COA, not just the specification
A specification tells you what the material is supposed to meet. A batch-specific Certificate of Analysis tells you what a particular lot was reported to meet.
That distinction is important.
Before approval, request a recent representative COA and check whether it includes:

Product identification
Batch or lot number
Manufacturing or test date
Assay result
Relevant impurity or related-substance results
Water or moisture, where applicable
Microbiological testing, where applicable
Residual solvents, where relevant
Elemental impurities, where relevant
Analytical methods or references to the applicable methods
Manufacturer or testing laboratory information

The COA should also be traceable to the actual batch being supplied.
For regulated or quality-sensitive applications, supply-chain transparency and valid certificates of analysis are important elements of supplier qualification. The U.S. FDA, for example, has emphasized the importance of valid COAs, supply-chain transparency and identification of the original manufacturer in its guidance for bulk ingredients and excipients. [5]
6. Verify the source and batch traceability
A supplier&#8217;s name and a manufacturer&#8217;s name are not necessarily the same thing.
For trading and distribution channels, buyers should understand who actually manufactures the material, where it is produced, and how the supplied batch can be traced.
Useful questions include:

Who is the original manufacturer?
Where is the material manufactured?
Is the quoted material manufactured by the same site shown on the documentation?
Can the batch number be traced through the supply chain?
Are manufacturing and packaging locations different?
Can supporting quality documents be provided for the actual production batch?

This becomes particularly important when comparing multiple quotations. Two suppliers may appear to offer the same NMN at different prices while actually sourcing from different manufacturers or using different quality-control systems.
Traceability therefore helps turn a quotation into a verifiable supply proposition.
7. Compare the complete supply package, not only USD/kg
Once the technical information has been confirmed, price becomes much more useful.
Instead of asking only:
“Who offers the lowest price?”
compare:
material + specification + analytical method + documentation + stability support + traceability + lead time + MOQ + logistics.
For example, Supplier A may quote a lower price but provide only a basic COA. Supplier B may quote a higher price but provide a detailed specification, batch-specific COA, MSDS, manufacturing information and supporting stability data.
That does not automatically make Supplier B the right choice. The point is that the two offers should not be treated as equivalent until the underlying specifications and documentation have been compared.
This approach also helps avoid a common procurement problem: approving a low-priced sample and discovering later that the documentation or quality profile does not meet the requirements of the finished-product project.
What should buyers request before approving an NMN or NAD+ supplier?
A practical first-round document request can be kept relatively simple:
1. Product specification2. Recent batch-specific COA3. MSDS/SDS4. Analytical method or method reference for assay and relevant impurities5. Recommended storage conditions and shelf-life information6. Manufacturing source and batch traceability information7. Regulatory or market-specific documentation where applicable
Not every project requires every document at the same stage. The appropriate documentation depends on the intended use, target market and regulatory framework.
The key is to establish the technical baseline before comparing commercial offers.
																														
Price is only meaningful after the material is defined
NMN and NAD+ are examples of why ingredient procurement should start with specification rather than price.
A lower quotation is not necessarily a problem, and a higher quotation is not necessarily better. What matters is whether the quoted materials are genuinely comparable in identity, assay, analytical methodology, impurity control, stability, documentation and traceability.
For newer ingredients, information quality is part of supply quality.
At Esubio, our Longevity & Cellular Health sourcing work focuses on ingredients such as NMN, NAD+ and related cellular-health actives. We work with supplier documentation including COA, MSDS and product specifications to help buyers establish the technical baseline before moving into commercial evaluation.
For emerging ingredients, the first question should not always be:
“What is your price?”
A better starting point is:
“What exactly are you supplying, how is it tested, and what documentation supports it?”
Once those questions are answered, the price comparison becomes much more meaningful.
References

PubMed — Degradation kinetics of β-nicotinamide mononucleotide based on reliable HPLC quantitative methodhttps://pubmed.ncbi.nlm.nih.gov/38212023/
[2] PubMed — A Novel HPLC Method for Quality Inspection of NRK Biosynthesized β-Nicotinamide Mononucleotidehttps://pubmed.ncbi.nlm.nih.gov/36617938/
[3] PubMed — Aqueous LC-MS/MS quantification of α-/β-nicotinamide mononucleotide in dietary supplementshttps://pubmed.ncbi.nlm.nih.gov/41545110/
[4] ICH — Stability Testing of New Drug Substances and Products Q1A(R2)https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf
[5] U.S. FDA — Know Your Bulk Drug Substances and Excipients Suppliershttps://www.fda.gov/drugs/human-drug-compounding/fda-compounders-know-your-bulks-and-excipients-suppliers
Additional reference — PubChem: β-Nicotinamide mononucleotidehttps://pubchem.ncbi.nlm.nih.gov/compound/16219737

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 4

Amino Acid Quality: 7 Powerful Checks Beyond 99% Purity

Accepted Answer

Home > Blog
Amino Acid Quality: 7 Powerful Checks Beyond 99% Purity
Amino Acid Quality is often reduced to one number: 99%, 99.5%, or 98%.
For procurement teams, purity is an important starting point. It tells you something about the amount of the intended substance relative to specified impurities or other components.
But it does not tell you everything you need to know about how an amino acid will behave in a real formulation.
Two amino acid powders can both meet a high-purity specification and still have differences in particle size, solubility, bulk density, physical form, odor, or manufacturing route.
Those differences may not be obvious when reviewing a basic specification sheet.
They can become much more obvious during formulation, processing, or scale-up.
That is why Amino Acid Quality should be evaluated as a complete specification rather than a single purity number.
																														
Why 99% Purity Does Not Tell the Whole Story
Purity answers an important question:
How much of the intended material is present?
But formulators often need answers to other questions:
Can the powder dissolve at the required concentration?
Will it flow consistently through the production process?
Will it behave properly during blending?
Does its particle size match the process?
Will bulk density affect filling or blending?
Is the manufacturing process appropriate for the intended application?
Can the supplier reproduce the same characteristics from batch to batch?
These are different questions.
For example, published technical data for L-arginine can include not only chemical identity and composition, but also water solubility, bulk density, and particle-size distribution. One EFSA assessment of fermented L-arginine reported these physical characteristics across batches, illustrating why physical properties can be relevant to evaluating an ingredient beyond its chemical assay. (efsa.europa.eu)
The practical lesson is simple:
High purity does not automatically mean high application suitability.
1. Start With Purity, But Don&#8217;t Stop There
Purity should still be one of the first checks when evaluating an amino acid.
A specification may include assay, related substances, moisture, residue on ignition, or other quality parameters depending on the ingredient and applicable standard.
But the right question is not:
“Is it 99%?”
It is:
“What does the complete specification tell me about this 99% material?”
A high assay with incomplete physical or application-related information may leave important questions unanswered.
For a formulation team, a material that meets chemical purity requirements but performs poorly during processing may create more cost than a slightly higher-priced material with better process compatibility.
This is why procurement and R&D should evaluate purity together with the characteristics that actually matter for the finished application.
2. Check Particle Size or Mesh Size
Particle size is one of the most practical parameters to consider for amino acid powders.
A specification such as 60 mesh, 80 mesh, or a defined particle-size distribution can provide information about the physical form of the material.
However, “mesh” and particle size are not always interchangeable in a simple way.
Mesh describes whether particles pass through a particular sieve, while particle-size distribution can provide a more detailed picture of the powder population.
Depending on the application, buyers may therefore need either a mesh specification, a particle-size distribution, or both.
Why does this matter?
Because particle size can affect powder handling, dissolution behavior, blending, dust generation, and other processing characteristics.
A powder that works well in a laboratory beaker may behave differently when hundreds of kilograms are blended or processed.
For this reason, particle size should be discussed in relation to the actual manufacturing process rather than treated as an isolated number.
3. Evaluate Solubility for the Actual Application
Solubility can be critical when an amino acid is intended for beverages, liquid formulations, or other applications where the ingredient must dissolve efficiently.
But “soluble in water” is not always enough information.
The practical result can depend on concentration, temperature, pH, formulation composition, and the physical characteristics of the ingredient.
For example, an ingredient may dissolve easily at a low concentration in laboratory water but behave differently when used at a higher dosage or in a more complex beverage system.
This is why the procurement specification should reflect the actual application whenever possible.
Instead of simply asking:
“Is it soluble?”
ask:
“At what concentration, temperature, and formulation conditions does it need to dissolve?”
That gives the supplier a much more useful technical target.
																														
4. Look at Bulk Density and Powder Handling
Bulk density is another parameter that can be overlooked when buyers focus heavily on purity.
It describes the mass of powder occupying a given bulk volume and can affect how a powder behaves during handling, storage, filling, blending, and transportation.
Two powders with the same chemical assay can occupy different volumes and behave differently in a production environment.
This can matter particularly for:

Tablet and capsule manufacturing
Powder blends
Sachets
Dry beverage mixes
Premixes
Large-scale blending

Research on powder processing also shows that bulk properties such as bulk density and particle-size characteristics can be relevant to powder flow and segregation behavior. (usp.org)
Not every amino acid needs a strict bulk-density specification.
But when powder handling is important to the application, it is worth discussing.
5. Understand the Manufacturing Route
The same amino acid can potentially be produced through different manufacturing routes depending on the specific substance and supplier.
Fermentation is commonly used for the production of certain amino acids, while other materials may be manufactured through chemical synthesis or other processes.
FDA&#8217;s Q7 GMP guidance specifically recognizes amino acids among low-molecular-weight products that can be produced through fermentation and describes the importance of process controls, purification, contamination control, and defined specifications for materials produced through such processes. (fda.gov)
This does not mean one manufacturing route is automatically better.
The relevant question is whether the manufacturing route, purification process, and resulting quality characteristics are appropriate for the intended use.
For procurement teams, understanding the manufacturing route can also help clarify questions about documentation, traceability, impurities, and supplier qualification.
6. Check Whether the Specification Matches the Application
This is where procurement can move beyond commodity purchasing.
Imagine two amino acid suppliers.
Both offer:
Assay: ≥99%
At first glance, they appear equivalent.
But Supplier A provides a particle-size range, solubility information, manufacturing-route information, complete CoA, and consistent batch documentation.
Supplier B provides only assay, appearance, and a basic identification test.
The price difference may be small.
But the amount of technical uncertainty is not.
For a simple application, Supplier B may still be perfectly suitable.
For a demanding formulation, however, the additional information from Supplier A may be much more valuable.
The point is not to request every possible specification for every amino acid.
It is to identify which parameters actually influence your formulation and production process.
A good specification is application-driven.
7. Compare the Approved Sample With the Commercial Batch
A sample can pass laboratory testing and still leave questions about commercial consistency.
This happens when the sample is evaluated against one set of expectations while the commercial purchase is controlled against another.
For example, R&D may approve a sample because it dissolves quickly and has a suitable powder appearance.
But the purchase specification may only state:
Assay ≥99%.
If the next commercial batch also meets ≥99% but has a different particle-size profile or bulk density, the material may behave differently during production.
This is why sample approval and commercial specifications should be connected.
Where physical characteristics are important, the agreed specification should define the relevant parameters and acceptance criteria before commercial supply begins.
The goal is not to guarantee that every batch will look exactly identical.
The goal is to establish measurable characteristics that help control meaningful variation.
A Better Amino Acid Specification
A useful amino acid specification should answer the questions that matter to the application.
Depending on the ingredient and intended use, it may include:
Identity and AssayWhat is the material and what is the required assay?
Physical CharacteristicsWhat are the appearance, particle size or mesh, and other relevant physical properties?
SolubilityWhat level of solubility is required under the intended application conditions?
Bulk DensityIs bulk density relevant to blending, filling, or processing?
Manufacturing RouteIs the material fermented, chemically synthesized, or produced through another route?
Safety and Purity ParametersWhich impurities, microbiological parameters, elemental impurities, or other safety-related characteristics need to be controlled?
Batch DocumentationCan the supplier provide a CoA and supporting specification for each commercial batch?
The exact specification should be based on the amino acid and its intended use.
More parameters do not automatically mean a better specification.
The right parameters do.
																														
From “99% Pure” to Application-Ready Sourcing
For procurement, a high-purity amino acid can be an excellent starting point.
But purity is only one part of the purchasing decision.
If the ingredient will be used in a tablet, capsule, powder blend, sports nutrition product, or beverage, its physical properties can become just as relevant as its chemical assay.
This is why Amino Acid Quality should be evaluated through the complete specification:
Purity → Particle Size → Solubility → Bulk Density → Manufacturing Route → Safety Parameters → Batch Consistency
At Esubio, our Amino Acids sourcing focuses on functional ingredient applications including sports nutrition and recovery-oriented formulations.
Depending on the product and supplier, documentation may include CoA, SDS/MSDS, product specifications, and other available supporting information.
For application-specific requirements, we can discuss parameters such as particle size, mesh, solubility, and other relevant physical characteristics with the supplier before commercial sourcing.
The objective is not simply to find an amino acid that passes a purity test.
It is to find a material that fits the formulation, manufacturing process, documentation requirements, and commercial supply expectations.
The Bottom Line
When comparing amino acid suppliers, “≥99%” is useful information.
It just should not be the only information.
A complete sourcing decision may need to consider:
What is the purity?
What is the particle size?
How does it dissolve under the intended conditions?
What is the bulk density?
How is it manufactured?
Which safety and impurity parameters are controlled?
Can the supplier maintain these characteristics across commercial batches?
The more closely the specification reflects the actual formulation and production process, the fewer surprises are likely to appear during scale-up.
For amino acid procurement, the goal is not simply to buy a high-purity powder.
It is to buy the right specification for the way that powder will actually be used.
References

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q7a-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients
FDA — Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients

https://pmc.ncbi.nlm.nih.gov/articles/PMC7009432/
EFSA — L-Arginine Physical Properties and Stability

https://cmkc.usp.org/a/cmkc-resources/RE1221/novel-methodology-to-assess-segregation-risk-in-a-continuous-direct-compression-via-mini-batch-blending-process
USP — Powder Flow, Bulk Density and Particle Size

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 5

Botanical Extract Quality: 7 Powerful Checks Beyond a 10:1 Ratio

Accepted Answer

Home > Blog
Botanical Extract Quality: 7 Powerful Checks Beyond a 10:1 Ratio
Botanical Extract Quality cannot be judged by one number alone.
Yet “10:1,” “20:1,” or “50:1” is often one of the first things buyers see when comparing botanical extracts.
The number looks precise.
But what does it actually tell you?
A plant-to-extract ratio describes the relationship between the amount of starting botanical material and the amount of extract obtained. It can be useful for understanding how an extract was produced and, in some cases, for dosage calculations.
But it does not fully describe what is inside the finished extract.
Two botanical extracts can both be labeled 10:1 and still have meaningfully different chemical profiles.
That is why Botanical Extract Quality requires more information than an extract ratio.
																														
Why a 10:1 Extract Ratio Is Not Enough
A 10:1 ratio generally indicates that approximately 10 parts of starting botanical material were used to produce one part of extract, subject to how the ratio is defined and calculated.
It does not automatically tell you:

Which plant species was used
Which plant part was extracted
Where the botanical material came from
Which extraction solvent was used
Which compounds are present
How much of a relevant marker compound is present
Which analytical method was used
Whether excipients were added
Whether the material meets the required contaminant limits

A technical review of plant-to-extract ratios published in Frontiers in Pharmacology notes that the ratio does not completely describe a botanical extract because starting material quality, extraction solvents, extraction temperature and duration, drying processes, and excipients can all influence the final composition.
So the important question is not:
“Is this extract 10:1?”
It is:
“What does the 10:1 extract actually contain, and how is that quality controlled?”
1. Check the Botanical Identity
The first step in assessing Botanical Extract Quality is confirming exactly what plant material you are buying.
The botanical name should be clear and, where relevant, should include the plant part used.
For example, “Ginseng Extract” provides much less information than a specification identifying the botanical species and plant part.
This matters because different species, subspecies, varieties, and plant parts can have different chemical profiles.
Identity can also require more than a name on a specification sheet.
Depending on the material and quality requirements, identification may involve macroscopic or microscopic examination, chemical testing, chromatographic methods, or other suitable analytical approaches.
WHO quality-control guidance for herbal materials includes identity testing and emphasizes that appropriate analytical methods should be selected for the material being evaluated.
For procurement teams, the practical question is simple:
Can the supplier clearly demonstrate what botanical material was actually used?
2. Look Beyond the Extract Ratio to Marker Compounds
An extract ratio tells you about the starting material-to-extract relationship.
A marker specification tells you more about the chemical characteristics of the finished ingredient.
For standardized botanical extracts, a specification may define one or more marker or characteristic constituents and establish a quantitative range.
This can be much more useful for comparing batches than an extract ratio alone.
For example, two suppliers may both offer a botanical extract described as 10:1.
Supplier A may specify a relevant marker compound at a defined percentage using a stated analytical method.
Supplier B may provide only “10:1” without any quantitative marker specification.
Those are not equivalent specifications.
USP-related guidance on botanical extracts also distinguishes between situations where active principles or marker compounds are known and situations where they are not. Where relevant, the content of identified active principles or marker compounds can be part of the extract description; the starting-material-to-final-product ratio is used when active principles are unknown.
This is one reason buyers should ask:
What exactly is standardized, and how is it measured?
3. Ask Which Analytical Method Is Used
A number without a method is difficult to evaluate.
Suppose a supplier states:
“Marker compound: 20%.”
The next question should be:
Measured by which method?
HPLC?
UV?
TLC?
Another validated analytical procedure?
The analytical method can affect how a result is generated and interpreted.
For botanical materials, chemical profiles can also be important because botanicals are complex mixtures rather than single purified compounds.
WHO guidance describes chemical profiling, including TLC/HPLC fingerprinting where appropriate, as part of botanical quality control and also recommends quantitative testing of chemical markers where applicable.
Therefore, a stronger botanical specification does not simply state a target number.
It connects:
Constituent → Specification → Analytical Method → Result
That connection makes the specification much more useful for quality evaluation.
4. Confirm the Plant Part, Origin, and Processing Information
Botanical variability can begin before extraction.
The plant species, plant part, geographic origin, agricultural conditions, harvesting, storage, and processing can all influence the starting material.
This is why “same plant + same ratio” does not necessarily mean “same extract.”
For higher-risk or more technically sensitive botanical ingredients, buyers may need more information about where the raw material comes from and how it is processed.
FDA&#8217;s botanical drug guidance, although written for botanical drug development rather than dietary supplement ingredients generally, illustrates this broader quality-control principle. It identifies botanical raw material information such as authenticity, agricultural practices, geographic location, collection, and processing methods as relevant to understanding botanical consistency.
For ingredient procurement, the lesson is not that every commercial botanical extract requires a pharmaceutical-level dossier.
The lesson is that raw-material information can matter when evaluating consistency and risk.
																														
5. Review Safety and Contaminant Specifications
A botanical extract may meet its marker specification and still require additional quality checks.
Botanical materials can carry risks associated with agricultural production, environmental exposure, processing, storage, or contamination.
Depending on the ingredient and destination market, relevant specifications may include:

Heavy metals
Pesticide residues
Microbiological limits
Mycotoxins
Residual solvents
Foreign matter
Other product-specific contaminants

WHO guidance on herbal material quality control specifically addresses testing for pesticide residues, arsenic and toxic heavy metals, microorganisms, aflatoxins, and other quality parameters.
The exact testing requirements should be determined according to the product, intended use, market, and applicable customer or regulatory requirements.
The important point is that Botanical Extract Quality is not only about potency or marker content.
It also includes purity and safety.
6. Check Whether the Specification Can Control Batch Consistency
This is where procurement and R&D often discover the limitations of an extract ratio.
Imagine that R&D approves a 10:1 botanical extract based on a successful sample.
Several months later, the next batch is also labeled 10:1.
But the color is different.
The aroma is different.
The marker level is lower.
The formulation behaves differently.
The buyer now has a problem.
The original specification may never have defined the parameters needed to control the differences.
A stronger specification should identify the characteristics that matter for the intended application.
Depending on the ingredient, that may include:
Identity → Marker/active constituents → Analytical method → Physical characteristics → Contaminant limits → Microbiological requirements → Packaging → Storage conditions
Not every botanical needs every parameter.
The right specification depends on the ingredient.
But the principle remains:
If a characteristic matters to product performance or quality, it should be defined and measurable whenever practical.
7. Compare the Sample and Commercial Batch Using the Same Specification
A successful sample does not automatically guarantee a successful commercial batch.
One reason is that the sample may have been evaluated using parameters that were never incorporated into the formal purchasing specification.
This creates a gap between:
What R&D approved
and
What procurement actually purchased.
To reduce this gap, the sample approval criteria and commercial specification should be aligned as closely as practical.
The same key identity requirements, marker specifications, analytical methods, physical characteristics, and safety parameters should be carried into the commercial supply process where appropriate.
The CoA for each commercial batch can then be reviewed against the agreed specification.
This makes the sample more than a one-time R&D exercise.
It becomes part of a controlled raw-material qualification process.
A Better Botanical Extract Specification
A useful botanical extract specification does not need to be unnecessarily complicated.
It needs to contain the information that actually controls the ingredient.
A practical framework is:
Botanical IdentityScientific name, plant part, and relevant identification requirements.
Extract DescriptionExtract ratio or DER where applicable, extraction method or solvent information where relevant, and excipient information if applicable.
StandardizationMarker or active constituent and its specified range, where applicable.
Analytical MethodThe method used to determine the specified constituent or quality parameter.
Safety ParametersRelevant microbiological and contaminant limits.
Physical ParametersAppearance, color, odor, particle size, moisture, or other application-specific characteristics where relevant.
Batch DocumentationCoA, specification, traceability information, and other agreed supporting documents.
The exact structure will vary from one botanical ingredient to another.
But this framework is far more informative than a single “10:1” statement.
																														
From Extract Ratio to Transparent Botanical Sourcing
For buyers, the extract ratio is not useless.
It simply should not be treated as the complete definition of an extract.
A 10:1 ratio can provide useful information about the relationship between starting botanical material and finished extract.
But Botanical Extract Quality depends on a broader set of factors.
The plant identity matters.
The plant part matters.
The starting material matters.
The extraction process matters.
The marker compounds may matter.
The analytical method matters.
The contaminant limits matter.
And the batch documentation matters.
At Esubio, our Botanical Extracts sourcing approach focuses on complete specifications and transparent documentation rather than presenting an extract ratio as the whole quality story.
Depending on the product and supplier, documentation may include specifications, CoA, SDS/MSDS, testing reports, traceability information, and other available supporting documents.
Where market-specific documentation is relevant, requirements are confirmed according to the actual product, destination market, and available supplier documentation.
The objective is simple:
Give buyers enough information to evaluate a botanical extract before they commit to commercial supply.
Because when the only number you have is “10:1,” you may know how concentrated the starting material was.
You may still not know what you are buying.
The Bottom Line
A botanical extract specification should answer more than one question.
Not just:
“What is the extract ratio?”
But also:
“What plant is it?”
“Which part was used?”
“What does the extract contain?”
“How is it measured?”
“What contaminants are controlled?”
“Can the same specification be applied batch after batch?”
The more clearly these questions are answered, the easier it becomes for procurement, quality, and R&D teams to make informed sourcing decisions.
A 10:1 extract may be a starting point.
It should not be the finish line for evaluating Botanical Extract Quality.
References

Understanding Plant to Extract Ratios in Botanical Extracts

WHO — Quality Control Methods for Herbal Materials

WHO — Herbal Processing and Quality Control Guidance

FDA — Botanical Drug Development: Guidance for Industry

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 6

7 Powerful Ways to Reduce Single-Source Supply Risk in Ingredient Procurement

Accepted Answer

Home > Blog
7 Powerful Ways to Reduce Single-Source Supply Risk in Ingredient Procurement
Single-source supply risk is easy to overlook when everything is running smoothly. One supplier provides the raw material, the documentation is already approved, the quality is familiar, and the purchasing process is predictable. From an operational perspective, staying with one source often feels efficient.
The problem appears when that source suddenly becomes unavailable.
For ingredient manufacturers, supplement brands, contract manufacturers, and other businesses that depend on imported raw materials, a supplier disruption can quickly become a production problem. Capacity constraints, unexpected price increases, quality deviations, transportation delays, export restrictions, or regional disruptions can all affect supply continuity.
The real question is not whether a single supplier can perform well today. It is whether the business can continue operating if that supplier cannot deliver tomorrow.
																														
Why Single-Source Supply Risk Is Often Hidden
A single-source strategy does not necessarily mean that a supplier is unreliable. In many cases, the supplier may have an excellent quality record, competitive pricing, and a long-standing relationship with the buyer.
The risk comes from concentration.
If one supplier represents 100% of the available supply for a critical ingredient, the buyer has very limited flexibility when conditions change. Even a reliable supplier can experience an unexpected production issue, raw material shortage, equipment failure, labor disruption, logistics problem, or temporary capacity constraint.
This creates a single point of failure.
The same principle applies geographically. A company may have several suppliers on paper, but if those suppliers depend on the same production region or upstream raw material source, the apparent diversification may provide less protection than expected.
Supply chain resilience therefore requires looking beyond the number of supplier names in a purchasing system. It requires understanding where critical materials come from and how quickly an alternative source could actually be activated.
1. Identify Critical Ingredients Before Adding Suppliers
Not every ingredient needs a second source.
The first step is to identify which raw materials could create the greatest operational or financial impact if supply stopped.
A practical assessment can consider:

Importance of the ingredient to the finished product
Monthly or annual purchasing volume
Available inventory coverage
Supplier lead time
Availability of qualified alternatives
Product-specific specifications
Regulatory or customer approval requirements
Geographic concentration
Impact of a supply interruption on production

A low-cost ingredient with many qualified suppliers may present little risk. A specialized botanical extract, probiotic strain, functional active, or customized blend with a long qualification cycle may represent a much greater exposure.
The goal is not to diversify everything. It is to prioritize the materials where a second source creates meaningful resilience.
2. Build a Qualified Backup Supplier, Not Just a Supplier List
Finding another company that can quote the same ingredient is not the same as having a backup supplier.
A genuine backup source should be capable of passing the same qualification process as the primary source.
That may include specifications, CoA review, analytical testing, manufacturing information, certifications, allergen information, regulatory documentation, packaging requirements, and other customer-specific requirements.
This is particularly important for food ingredients, dietary supplement ingredients, botanicals, probiotics, amino acids, and specialty functional ingredients.
If a backup supplier has never been evaluated, its value during an emergency may be limited. The organization may still need several weeks or months to complete qualification before placing a production order.
Supplier diversification therefore works best when qualification happens before the disruption.
3. Standardize Specifications and Documentation
One hidden barrier to supplier diversification is inconsistent documentation.
A primary supplier may already understand the buyer&#8217;s required specification, packaging format, labeling requirements, testing methods, and documentation package. A new supplier may provide the same ingredient under a different specification or with incomplete supporting documents.
This creates additional work for purchasing, quality, regulatory, and R&D teams.
Standardizing the information required from suppliers can make switching much easier.
For example, a qualification package may include:

Product specification
Certificate of Analysis
Safety Data Sheet where applicable
Country of origin
Manufacturing information
Allergen statement
GMO status
Microbiological requirements
Heavy metal and contaminant limits
Stability or storage information where relevant
Packaging and shelf-life information

The exact requirements depend on the ingredient and market, but the principle is straightforward: the more standardized the qualification process, the easier it becomes to activate another source.
4. Test Supply Continuity Before You Need It
A supplier can look qualified on paper and still be difficult to use in practice.
This is why an occasional trial order can be more valuable than simply keeping a supplier&#8217;s contact information in a database.
For critical materials, buyers can consider small validation orders or sample-to-batch comparisons before an emergency occurs.
This helps answer practical questions:
Can the supplier meet the required specification?
Can the material be supplied within the required lead time?
Is the batch-to-batch quality consistent?
Can the supplier provide the required documentation?
Can the packaging withstand international transportation and storage conditions?
Can the supplier respond quickly when an RFQ becomes urgent?
These questions turn a theoretical backup supplier into a potentially usable supply option.
																														
5. Consider Dual Sourcing Where the Risk Justifies the Cost
Dual sourcing does not necessarily mean splitting purchases 50/50.
Depending on the material, a company may maintain one primary supplier for most of its volume while keeping a qualified secondary supplier available for a smaller allocation.
For example, a procurement strategy could use one supplier for the majority of annual demand while periodically purchasing from a second source to maintain qualification and commercial familiarity.
This approach may cost more than pure single sourcing. There may be lower volume discounts, additional qualification work, separate logistics arrangements, or more supplier management.
However, the relevant comparison is not simply supplier price.
The better question is:
What is the cost of maintaining a backup source compared with the cost of production downtime caused by a supply interruption?
The answer will differ by ingredient and business model, but the risk should be evaluated against the potential cost of disruption.
6. Look Beyond Price When Evaluating Ingredient Suppliers
A lower quotation does not automatically create a lower procurement cost.
For critical ingredients, supplier evaluation should consider total supply performance, including quality, lead time, documentation, responsiveness, MOQ, payment terms, logistics flexibility, and consistency.
A supplier offering a slightly higher price may create greater value if it provides shorter lead times, lower MOQs, reliable documentation, or a more flexible response during shortages.
This is especially relevant for international ingredient sourcing, where transportation, customs procedures, documentation, and regional supply conditions can affect the final landed cost and delivery timeline.
Price remains important. It simply should not be the only variable.
7. Maintain an Active Supply Option Before a Disruption Happens
The biggest mistake in supplier diversification is waiting until the primary supplier fails.
Once a shortage occurs, every buyer is competing for alternative capacity. Lead times become longer, prices may rise, and qualification teams have less time to evaluate new suppliers properly.
A better approach is to build supply flexibility while the existing supplier is still performing normally.
This does not require maintaining large inventories or continuously purchasing from multiple sources.
It means knowing:

Who the potential alternative suppliers are
Which suppliers have already been qualified
Which documents have been reviewed
Which specifications have been confirmed
Whether samples have been tested
What MOQ and lead time they can support
How quickly they could respond to an urgent requirement

That information turns supplier diversification from a theoretical strategy into an operational capability.
																														
From Single Sourcing to Supply Flexibility
Single sourcing can be efficient. It can simplify communication, consolidate purchasing volume, and reduce supplier-management workload.
The problem begins when efficiency becomes dependency.
A resilient ingredient procurement strategy does not necessarily require dozens of suppliers. It requires enough qualified alternatives for the materials where supply interruption would have a meaningful business impact.
Research from McKinsey has highlighted dual sourcing, supplier diversification, and supply network redesign as important measures for improving supply chain resilience. The OECD has similarly emphasized diversification and proactive risk management as part of strengthening global supply chains.
For ingredient buyers, the practical lesson is simple: do not wait for a supply disruption to discover that your second source is not ready.
Esubio supports international ingredient sourcing across botanical extracts, amino acids, probiotics, functional blends, and other functional ingredients. Through a verified-supplier approach, we help buyers evaluate additional sourcing options, review product documentation, and maintain greater flexibility beyond an existing supply structure.
The objective is not to replace a supplier that is already performing well.
It is to make sure that when circumstances change, there is another qualified path available.
In global ingredient procurement, the strongest supply chain is not necessarily the one with the lowest number of suppliers.
It is the one that can keep moving when one supplier cannot.
References

McKinsey — Global Supply Chain Leader Survey 2024
2. McKinsey — Risk, resilience, and rebalancing in global value chains
3. Deloitte — Supply Chain Resilience
4. OECD — Strengthen and Diversify Supply Chains
5. McKinsey — Supply Chain Stress Test

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 7

Supplier Qualification: 7 Powerful Ways to Reduce Costly Sourcing Delays

Accepted Answer

Home > Blog
Supplier Qualification: 7 Powerful Ways to Reduce Costly Sourcing Delays
For many dietary supplement and functional food projects, the formulation itself is not always what slows the project down.
Sometimes, the delay starts much earlier.
It starts when the team needs to find a new ingredient supplier.
A new ingredient may look simple on paper. The procurement team sends an RFQ, receives several quotations, requests samples, and compares prices.
But before a new supplier can actually become a reliable source, there is another layer of work.
Documents need to be reviewed. Certifications need to be checked. Specifications need to be compared. Manufacturing capabilities need to be assessed. Samples need to be tested. Questions need to be answered. Quality and procurement teams may need to review the supplier separately.
This is the hidden workload behind Supplier Qualification.
And when every new ingredient requires a completely new supplier search, the workload can become surprisingly large.
																														
Why Supplier Qualification Can Slow Down Ingredient Sourcing
Supplier qualification is not simply checking whether a company can offer a lower price.
A proper supplier evaluation may involve reviewing technical capabilities, quality systems, certifications, capacity, documentation, product consistency, communication, and other factors relevant to the purchasing decision.
Professional procurement organizations also treat supplier evaluation as an ongoing activity rather than a one-time price comparison. CIPS, for example, describes supplier evaluation as a process for evaluating and approving potential suppliers, with methods ranging from desk appraisal to field research and third-party assessment.
For ingredient buyers, this means a new supplier can create a significant amount of work before the first commercial order is even placed.
Imagine a formulation team needs one new botanical extract.
Procurement finds four possible suppliers.
Four suppliers may mean four sets of specifications, four document packages, four sample discussions, four rounds of questions, four sets of certification checks, and potentially four separate quality evaluations.
The ingredient itself has not changed.
But the verification workload has multiplied.
1. Separate Supplier Discovery From Supplier Qualification
One reason sourcing projects become inefficient is that supplier discovery and supplier qualification are treated as the same task.
They are not.
Supplier discovery answers:
“Who can potentially supply this ingredient?”
Supplier qualification asks:
“Which of these suppliers can reliably meet our requirements?”
The first stage is about finding options.
The second stage is about reducing risk.
This distinction matters because procurement teams should not spend the same amount of time evaluating every company they find online.
A more efficient approach is to establish an initial screening process before detailed qualification begins.
Basic screening can include product availability, specification match, production capability, relevant certifications, documentation availability, MOQ, lead time, and target market experience.
Only suppliers that pass the initial screening need to move into deeper evaluation.
This creates a more efficient funnel:
Market Search → Initial Screening → Supplier Qualification → Sample → Approval → Commercial Supply
2. Standardize the Qualification Checklist
Another hidden source of wasted time is starting from zero every time a new supplier appears.
One person asks for a certificate.
Another asks for a specification.
Quality asks for testing information.
Procurement asks about MOQ.
Then someone realizes that the manufacturer information was never confirmed.
A standardized Supplier Qualification checklist can prevent this.
For functional ingredients, the checklist may cover areas such as:

Company and manufacturing information
Product specification
CoA availability
Relevant certifications
Quality management system
Manufacturing capacity
MOQ and lead time
Packaging options
Batch traceability
Testing capabilities
Sample availability
Export experience
Destination-market requirements

The exact checklist should depend on the ingredient and risk level.
A low-risk commodity ingredient does not necessarily require the same depth of assessment as a highly specialized probiotic, botanical extract, or ingredient with strict customer specifications.
The principle is to make the evaluation structured and repeatable.
3. Don&#8217;t Treat Certifications as the Entire Qualification
A certificate can be useful evidence.
It is not the entire supplier evaluation.
A supplier may have ISO or HACCP-related certifications, but the buyer may still need to understand whether the actual product specification, manufacturing capability, testing process, traceability, and supply performance meet the project&#8217;s requirements.
CIPS similarly identifies technical capability, capacity, financial considerations, reliability, and certifications as relevant elements of supplier selection.
This is particularly important for ingredient sourcing.
A supplier may have the right certificate but not have the right grade.
Another may have the right product but an MOQ that is unsuitable for an early-stage project.
Another may provide an attractive sample but have limited commercial production capacity.
Supplier qualification therefore needs to connect documentation with actual supply capability.
4. Make Sample Evaluation Part of Qualification
A sample should not be treated as a completely separate step from supplier evaluation.
It is one of the most useful ways to connect supplier claims with actual product performance.
For example, procurement may receive a specification showing the correct assay and appearance.
But the R&D team still needs to determine whether the ingredient works in the formulation.
The quality team may also need to check whether the sample meets internal specifications.
This is why an efficient qualification process should connect:
Supplier → Documentation → Sample → Testing → Approval
Rather than:
Supplier Search → Supplier Review → Start Again → Sample Search → More Review
The second process creates repeated work.
The first creates a more connected sourcing workflow.
																														
5. Build a Reusable Qualified Supplier Network
This is where the biggest efficiency gain can come from.
If every new project starts with a blank page, procurement has to repeat the same supplier qualification work again and again.
But a qualified supplier network creates institutional knowledge.
Once a supplier has been reviewed, the information does not have to disappear when the project ends.
The supplier&#8217;s product categories, specifications, certifications, documentation, MOQ, lead times, sample history, and previous performance can become part of a reusable sourcing database.
This does not mean a supplier should be permanently approved for every future ingredient.
Product-specific qualification may still be necessary.
It means the next sourcing project starts with a better information base.
Instead of asking:
“Who can supply this?”
the team can begin with:
“Which qualified sources already exist in our network?”
That is a much faster starting point.
6. Use Supplier Performance to Update Qualification
Supplier qualification should not end when the first order is approved.
Actual supply performance provides information that documents and samples cannot fully show.
Procurement teams can monitor areas such as:

Batch consistency
Delivery performance
Documentation accuracy
Response time
Complaint handling
Specification compliance
Packaging condition
Commercial reliability

CIPS notes that supplier performance can be assessed through indicators such as product quality, delivery accuracy, lead times, customer service, and commercial performance.
This creates an important feedback loop:
Qualification → Purchase → Performance → Re-evaluation
A supplier that performs well becomes a stronger source.
A supplier with repeated quality or delivery problems may need corrective action, closer monitoring, or replacement.
This makes supplier qualification a living process rather than a one-time approval form.
7. Let Procurement Focus on Decisions, Not Repeated Verification
The real problem is not that supplier qualification takes work.
It should take work.
The problem is when highly skilled procurement, quality, and R&D teams repeatedly spend their time collecting the same basic information from completely new suppliers.
Their time is more valuable when it is spent on decisions.
Which specification is appropriate?
Which supplier provides the best risk-to-cost balance?
Does the sample work in the formulation?
Can the supplier support scale-up?
Is there a suitable backup source?
What commercial terms make sense?
These are higher-value questions.
A sourcing partner can help reduce the lower-value repetition by maintaining access to screened suppliers, collecting standard documentation, coordinating samples, and organizing the initial supplier information.
The final qualification decision should still remain with the buyer&#8217;s procurement and quality teams.
The goal is not to remove control.
It is to reduce unnecessary friction before that decision is made.
Supplier Qualification Is a Process, Not a Document
A common mistake is to think of supplier qualification as a folder containing certificates and questionnaires.
In reality, it is a process.
A more effective model looks like this:
Requirement → Supplier Discovery → Initial Screening → Qualification → Documentation → Sample → Testing → Approval → Performance Monitoring
Each stage reduces a different type of uncertainty.
Supplier discovery reduces search uncertainty.
Qualification reduces supplier risk.
Documentation reduces information gaps.
Sampling reduces product-performance uncertainty.
Performance monitoring reduces long-term supply risk.
When these stages are connected, supplier qualification becomes much more efficient.
																														
From Supplier Search to Supplier Network
This is also why a sourcing partner can create value beyond simply providing another quotation.
The real value is not:
“Here are three suppliers.”
It is:
“Here are suitable sources, the relevant product information, available documentation, samples, and the information needed for your team to make a qualification decision.”
At Esubio, we work with a verified supplier network for functional ingredients, including botanical extracts, amino acids, probiotics, postbiotics, and other specialty ingredients.
Depending on the product, supplier documentation may include specifications, CoA, SDS/MSDS, certifications, testing reports, and other available supporting information.
Where applicable, suppliers in our network may operate under ISO- or HACCP-based quality systems. Specific certifications and documents are confirmed according to the actual supplier and product rather than assumed across the entire portfolio.
The objective is straightforward:
Reduce the repeated work required to find, screen, document, sample, and communicate with new ingredient sources.
What a More Efficient Supplier Qualification Model Looks Like
A traditional sourcing process often looks like:
New Ingredient → Search → Contact Supplier → Collect Documents → Verify → Request Sample → Review → Start Again
A more efficient model can look like:
Ingredient Requirement → Screened Supplier Network → Qualification → Documentation → Sample → Buyer Approval → Commercial Supply
The second model does not eliminate due diligence.
It makes due diligence more reusable.
That distinction matters.
The purpose of a sourcing partner is not to tell a buyer which supplier to approve.
It is to help reduce the time and effort required to reach an informed decision.
For fast-moving supplement and functional food projects, that can make a meaningful difference.
Because sometimes the biggest delay in R&D is not the formulation.
It is everything that has to happen before the formulation can properly begin.
And when Supplier Qualification becomes a reusable capability rather than a repeated project-by-project task, procurement and quality teams can spend more of their time on the decisions that actually move the project forward.
References

Chartered Institute of Procurement & Supply. (n.d.). Supplier evaluation: How to evaluate suppliers. CIPS.
Chartered Institute of Procurement & Supply. (n.d.). Supplier selection: What is the supplier selection process?. CIPS.
Chartered Institute of Procurement & Supply. (n.d.). Supplier performance: How to manage supplier performance. CIPS.
Chartered Institute of Procurement & Supply. (n.d.). The procurement process. CIPS.
Chartered Institute of Procurement & Supply. (n.d.). Managing suppliers. CIPS.
Chartered Institute of Procurement & Supply. (n.d.). What is procurement?. CIPS.
Association for Supply Chain Management. (2024). Supplier relationship management certificate: Module 5—Supplier risk management. ASCM.
Association for Supply Chain Management. (n.d.). Supplier relationship management certificate. ASCM.

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 8

Supplier Qualification: 7 Smart Ways to Cut Ingredient Sourcing Time

Accepted Answer

Home > Blog
Supplier Qualification: 7 Smart Ways to Cut Ingredient Sourcing Time
Supplier qualification is often treated as a routine procurement task. In reality, it can become one of the biggest hidden time costs in ingredient development.
A new ingredient may look simple on paper: identify a supplier, request a quotation, receive a COA, order a sample, and start testing.
But experienced procurement and quality teams know that the real process is rarely that straightforward.
Before a new raw material supplier can be considered reliable, someone usually needs to review certifications, specifications, COAs, manufacturing information, quality systems, production capability, documentation, sample consistency, and sometimes audit records.
If three or four suppliers are being evaluated at the same time, the workload increases quickly.
The result is a common situation: the formulation itself is ready to move forward, but the project is still waiting for the supply side to be qualified.
																														
Why supplier qualification takes longer than expected
The biggest problem is not that supplier qualification is unnecessary. It is that much of the work is repetitive.
For a new ingredient, procurement may need to ask:
Is the company a manufacturer or trader?
Where is the actual manufacturing site?
Does the certification apply to the production facility?
Is the current COA representative of the material being offered?
Can the supplier provide the required specification?
Can the supplier consistently meet the specification?
What is the MOQ?
What is the normal lead time?
Can the supplier support future commercial volumes?
Are the packaging, storage and transportation conditions suitable?
These questions are individually reasonable. The problem appears when the same process has to be repeated for every new supplier.
For companies developing multiple formulas or working with dozens of functional ingredients, supplier qualification can quietly become a bottleneck.
FDA guidance also treats supplier approval and verification as a risk-based activity rather than a simple document collection exercise. Depending on the material and risk involved, supplier evaluation can include records review, testing, audits and ongoing verification.
That distinction matters.
A supplier having an ISO certificate does not automatically mean that a specific ingredient is suitable for a specific application.
A COA shows analytical results for a batch. It does not, by itself, prove that the supplier will consistently produce every future batch to the same standard.
Supplier qualification therefore needs to connect three things: the supplier, the material, and the actual application.
What should supplier qualification actually verify?
A practical supplier qualification process normally covers several layers.
First is company and manufacturing information.
The buyer needs to understand who is actually producing the material, where it is manufactured, and whether the production site matches the documentation provided.
Second is quality system information.
Depending on the ingredient and application, this may include ISO, HACCP, GMP or other relevant certifications. The important question is not simply whether a certificate exists, but whether the certification is relevant to the manufacturing site and product category.
Third is product documentation.
Specifications, COAs, MSDS/SDS, microbiological limits, heavy metal limits, allergen information, residual solvent data and other technical documents may be required depending on the ingredient.
Fourth is historical performance.
This is often overlooked.
A supplier can provide a technically acceptable sample and still become a problem later if batch-to-batch consistency is poor, lead times are unstable, or documentation changes without proper communication.
Codex guidance similarly emphasizes written ingredient specifications, supplier records, COAs and periodic verification rather than relying on a single document or shipment.
The objective is therefore not to collect the largest possible number of documents.
The objective is to build enough evidence to make a reasonable purchasing decision.
The hidden cost of qualifying multiple suppliers
Consider a simple sourcing project.
A customer needs one botanical extract.
Procurement identifies four potential suppliers.
Each supplier requires:

Company and factory information
Certifications
Product specification
Recent COA
Sample
MOQ and pricing
Production lead time
Packaging information
Additional quality documents

Even if each supplier requires only a few hours of internal work, the total effort can become significant.
Then comes the second stage.
The samples arrive. R&D tests them. Quality compares analytical results. Procurement asks follow-up questions. One supplier cannot meet the MOQ. Another cannot provide the required documentation. A third supplier&#8217;s sample works, but its commercial lead time is too long.
																														
The project may have spent several weeks determining something that looked simple at the beginning:
Which supplier can actually support the project?
This is why supplier qualification should be viewed as a sourcing capability, not merely an administrative task.
7 ways to make supplier qualification more efficient
1. Start with the material risk, not the supplier list
Not every ingredient requires exactly the same level of qualification.
A low-risk ingredient and a critical active ingredient should not necessarily follow an identical verification process.
Risk, application, regulatory requirements, intended market and product sensitivity should determine how deeply the supplier is evaluated.
A risk-based approach prevents procurement teams from spending excessive time on low-impact materials while critical materials receive insufficient attention.
FDA materials-management guidance similarly emphasizes risk-based supplier qualification and ongoing monitoring for critical raw materials.
2. Verify the manufacturing source early
One of the most useful questions to ask at the beginning is:
Who actually manufactures this material?
This can prevent a long qualification process from being built around the wrong counterpart.
If the supplier is a distributor, the buyer may also need to understand the original manufacturer, manufacturing location and traceability of the material.
Knowing the real source early makes later quality and documentation checks much more efficient.
3. Request the core technical package together
Instead of requesting documents one by one, create a standard document checklist.
For example:
Company profile, manufacturing information, certification, product specification, recent COA, SDS/MSDS, packaging details, MOQ and lead time.
This reduces email cycles and makes supplier comparison easier.
More importantly, it creates a consistent qualification framework across suppliers.
4. Treat the COA as evidence, not proof
A COA is important, but it should not become a substitute for supplier qualification.
The useful questions are:
Does the COA match the agreed specification?
Are the analytical methods identified where necessary?
Is the batch information clear?
Are the results realistic and internally consistent?
Can the supplier provide historical batch information when required?
For higher-risk materials, buyers may also need independent or incoming testing to verify supplier results.
FDA guidance specifically discusses verifying the reliability of supplier analytical results rather than assuming that a supplier COA is automatically sufficient.
5. Evaluate consistency, not just the first sample
A good sample is the beginning of supplier qualification, not the end.
A supplier should ultimately demonstrate the ability to repeatedly meet the agreed specification.
This is particularly important for standardized extracts, probiotics, functional blends and other ingredients where specification compliance and batch consistency directly affect formulation performance.
A supplier that performs well once but cannot maintain consistency may create more cost than a slightly more expensive but stable source.
6. Separate supplier qualification from price comparison
Price is important, but it should not be the first filter.
A lower quotation is not necessarily a lower procurement cost if the supplier requires repeated document follow-ups, has inconsistent lead times, fails incoming testing or cannot support future volume.
A more useful comparison includes:
Price + qualification effort + quality risk + lead time + documentation reliability + supply continuity.
That is closer to the supplier&#8217;s actual procurement cost.
7. Build a reusable supplier network
This is where the biggest efficiency gain can occur.
If every new ingredient requires starting from zero, supplier qualification remains an ongoing bottleneck.
But if a sourcing partner has already built a network of qualified suppliers, the process changes.
Instead of receiving a random list of suppliers, the buyer can begin with sources that have already been screened for basic company information, documentation and product capability.
The buyer still needs to conduct its own final qualification where required. But the amount of repetitive discovery work can be significantly reduced.
																														
Supplier qualification should reduce risk without slowing innovation
The purpose of supplier qualification is not to create another administrative layer.
It is to reduce the probability that a promising formulation reaches the next stage and then fails because the raw material source cannot support it.
The most efficient sourcing model therefore does not eliminate qualification.
It moves qualification earlier, makes the process more structured, and avoids repeating the same supplier discovery work for every project.
For ingredient buyers, this can make a meaningful difference.
Instead of spending weeks answering the question, “Which supplier can we trust enough to test?”, procurement and R&D can spend more time answering the question that actually matters:
“Does this ingredient work for our product?”
At Esubio, we work with a verified-supplier approach for functional ingredients and raw materials, with supplier documentation and technical information reviewed before products are presented to customers.
Depending on the ingredient and project requirements, documentation may include specifications, COA, SDS/MSDS and relevant quality certifications.
The goal is not to replace the buyer&#8217;s own quality system or supplier approval process.
It is to reduce the amount of repetitive sourcing work required before that process can begin.
Because in ingredient development, the hidden cost is not always the price of the raw material.
Sometimes, it is the weeks spent trying to establish whether the source behind it is reliable enough to move forward.
References

FDA — Supplier Approval and VerificationFDA Supplier Approval and Verification Guidance
FDA — Supplier Evaluation ResourcesFDA Supplier Evaluation Resources
FDA — Materials Management / Supplier QualificationFDA Materials Management Guidance
Codex / FAO — Ingredient Supplier VerificationFAO/Codex Food Hygiene Guidance

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 9

Customs Clearance Documents: 7 Powerful Ways to Prevent Costly Delays

Accepted Answer

Home > Blog
Customs Clearance Documents: 7 Powerful Ways to Prevent Costly Delays
Many ingredient buyers think delivery time is mainly determined by production.
Until a shipment is sitting at the port.
The goods may already be produced, packed, and ready for delivery. But if a required document is missing, incomplete, inconsistent, or needs additional verification, the shipment may not move as planned.
This is where Customs Clearance Documents become more than paperwork. They can directly affect the timing of your raw material supply chain.
For dietary supplement manufacturers, OEM factories, and ingredient buyers, a few days of delay can mean a delayed production schedule, postponed customer delivery, or additional storage and logistics costs.
Why Customs Clearance Documents Can Affect Delivery
International ingredient shipments involve more than the physical movement of goods.
Depending on the product, destination market, importer, intended use, and applicable regulations, the shipment may require different types of commercial, technical, quality, or regulatory documentation.
Common examples may include:

Commercial Invoice
Packing List
Bill of Lading or Air Waybill
Certificate of Analysis (CoA)
Product Specification
Safety Data Sheet (SDS/MSDS), where applicable
Certificate of Origin
Product or ingredient declarations
Testing reports
Market- or product-specific certificates or supporting documents

Not every shipment requires every document.
That is exactly why documentation needs to be checked before shipment rather than handled as a last-minute task.
For example, the U.S. FDA notes that incomplete or inaccurate entry information can result in additional review, and importers may need to provide supporting documentation depending on the product and entry.
In Australia, importers are expected to check the specific requirements applicable to their goods, including documentation requirements, before arrival. The BICON system is used to determine applicable import conditions and supporting documentation.
																														
The lesson is simple:
The right documents should be identified before the goods leave the country of export.
1. Start With the Destination Market, Not the Supplier
One common mistake is to ask the supplier:
“Which documents do you normally provide?”
That is useful, but it is not enough.
The better question is:
“What documents will this shipment require in the destination market?”
The supplier&#8217;s standard document package may not match the importer&#8217;s actual requirements.
A buyer may need a specific testing report, declaration, certificate, label information, manufacturer information, or other supporting document depending on the product and market.
For this reason, documentation requirements should be reviewed during the sourcing stage.
The destination market should be part of the purchasing specification—not something checked after the goods are already on the water.
2. Confirm Documentation Before Placing the Order
The easiest time to solve a documentation problem is before production starts.
Before confirming an order, buyers should ideally check:

Product specification
Required testing parameters
CoA requirements
Packaging and labeling information
Manufacturer information
Origin information
Required certificates
Testing reports
Importer or customs broker requirements

This does not mean preparing every possible document for every shipment.
It means identifying the documents that could become a condition for release, inspection, customer approval, or internal quality acceptance.
A five-minute documentation check before ordering can be much cheaper than solving a documentation problem after arrival.
3. Make the CoA Part of the Shipment Plan
For many functional ingredients, the CoA is one of the most important quality documents.
It connects the physical batch with its test results and specifications.
However, buyers should not assume that any CoA is automatically sufficient.
The required parameters may differ between products and customers. Some buyers may require additional testing for contaminants, microbiology, heavy metals, pesticides, allergens, or other product-specific parameters.
The key question is not simply:
“Do you have a CoA?”
It is:
“Does the CoA contain the information required for this specific shipment and approval process?”
This distinction can prevent unnecessary document revisions after production.
4. Check Whether Additional Testing Is Needed
A standard CoA may not cover every requirement.
Depending on the ingredient and destination market, buyers may request additional analytical reports or supporting documents.
For example, an importer may have internal specifications that require testing beyond the supplier&#8217;s routine release specification.
If an additional report is discovered only after shipment, the buyer may need to wait for the supplier or laboratory to provide it.
That can create an avoidable bottleneck.
The better approach is to identify additional testing requirements before production or shipment and determine whether the testing will be completed by the manufacturer, an independent laboratory, or another qualified party.
 
																														
5. Keep Commercial and Technical Documents Consistent
Another common problem is inconsistency between documents.
For example:
The product name on the invoice is different from the name on the CoA.
The manufacturer shown on one document is different from the manufacturer information provided elsewhere.
The batch number does not match.
The quantity or packaging description is inconsistent.
The origin information is unclear.
Each issue may look small, but together they can create questions for the importer, customs broker, quality team, or regulatory reviewer.
A simple pre-shipment document check should therefore compare key information across the document set:
Product → Manufacturer → Batch → Quantity → Origin → Packaging → Specification
Consistency is often as important as completeness.
6. Prepare Market-Specific Documents Before Shipment
Different markets can have different documentation and compliance expectations.
For example, Australian food importers are required to comply with applicable biosecurity and food safety requirements, and the Australian authorities specifically advise importers to check applicable documentation before goods arrive.
In Europe, traceability requirements can also be relevant to food and ingredient supply chains. EU rules require food and feed operators to be able to identify their suppliers and the businesses to which products have been supplied.
This does not mean every European ingredient shipment requires the same documents, or that every Asia-Pacific shipment requires Halal documentation.
The practical point is different:
Documentation should be matched to the actual product, destination, and customer requirement.
A good sourcing partner should therefore ask about the destination market early instead of simply sending the same standard document package to every customer.
7. Treat Documentation as Part of Lead Time
This is perhaps the most important point.
When calculating delivery time, buyers often think in terms of:
Production → Packing → Shipping → Arrival
A more realistic international sourcing process is:
Requirement → Supplier Confirmation → Production → Testing → Documentation → Shipping → Customs Clearance → Delivery
Documentation is therefore part of the supply chain timeline.
If a required report takes several days to prepare, that time should be considered before shipment.
If a certificate needs verification, that should also be considered.
If the importer needs documents before the cargo arrives, they should be sent in advance.
The objective is not to eliminate every possible customs inspection or regulatory delay. Those are not always under the supplier&#8217;s control.
The objective is to eliminate delays caused by documentation that could have been prepared earlier.
A Better Approach: Build a Pre-Shipment Document Checklist
For recurring ingredient purchases, a simple document checklist can significantly improve communication between procurement, quality, logistics, and suppliers.
A practical checklist can include:
1. Commercial documentsInvoice, packing list, shipping documents and origin information.
2. Quality documentsCoA, specification and applicable testing reports.
3. Safety documentsSDS/MSDS and other applicable safety information.
4. Regulatory documentsMarket- or product-specific declarations and certificates where required.
5. Traceability informationManufacturer, batch/lot number, production information and relevant supply-chain records.
6. Customer-specific requirementsAny additional documents requested by the buyer, OEM, importer, or quality team.
The exact checklist should always be confirmed for the specific product and destination.
																														
From “Document Supplier” to “Supply Chain Support”
For ingredient buyers, documentation should not be treated as something added to the shipment at the last minute.
It is part of the supply process.
At Esubio, we support ingredient sourcing for markets including the US, EU, Asia-Pacific, Australia & New Zealand, and the Middle East.
Depending on the product and customer requirements, shipment documentation may include CoA, SDS/MSDS, specifications, testing reports, origin information, and other applicable supporting documents.
For market-specific requirements, we confirm availability and applicability before shipment rather than assuming that one document package works for every market.
Our goal is straightforward:
Have the right documents ready before the goods arrive—not start looking for them after the shipment is already at the port.
What a More Reliable Ingredient Supply Process Looks Like
A reliable cross-border ingredient supply chain is not only about production capacity or freight rates.
It also depends on how early potential problems are identified.
A stronger process looks like this:
Requirement → Supplier Qualification → Documentation Check → Production → Testing → Pre-Shipment Review → Shipment → Customs Clearance → Delivery
When documentation is built into the sourcing process from the beginning, procurement teams have better visibility, suppliers have clearer requirements, and logistics teams have fewer last-minute issues to resolve.
In international ingredient sourcing, a shipment can be physically ready and still not be operationally ready.
That is why Customs Clearance Documents deserve attention before the cargo leaves the country of origin.
The goal is not simply to ship faster.
It is to make the entire supply process more predictable.
References

U.S. FDA — FDA Import ProcessFDA Import Process
U.S. FDA — Documents Required StatusFDA Documents Required Status
Australian Department of Agriculture — How to import food into AustraliaAustralia Food Import Guide
Australian Department of Agriculture — Documentary requirementsAustralian Documentary Requirements
European Commission — Traceability and Labelling

HOT NEWS
TALK TO US
请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message *			
			Send

Question 10

Raw Material Stability: Why a Passing Sample Is Not Enough for Shelf Life

Accepted Answer

Home > Blog Raw Material Stability: Why a Passing Sample Is Not Enough for Shelf Life A sample that passes testing today does not automatically mean the same ingredient will perform well throughout an 18-month shelf life.This is one of the easiest things to overlook during raw material qualification. A sample arrives, the COA looks good, the specification is met, the formulation works, and the project moves forward.But a laboratory result is only a snapshot in time.Raw material stability is a longer-term question. Temperature, humidity, light, oxygen, moisture exchange, processing conditions and packaging can all affect how an ingredient performs over time.For supplement manufacturers, the real question is not simply:“Does this sample meet specification?”It is:“How likely is this material to remain suitable under the conditions in which it will actually be stored, processed and used?” Why Raw Material Stability Matters After the Initial Test Consider a typical development process. A manufacturer receives a botanical extract or probiotic ingredient. The initial sample meets the specification. The formulation performs as expected, and the finished product moves toward commercialization. Several months later, stability samples are tested. The active marker has declined. The powder has changed color. The material has started to cake. Moisture has increased. Or, in the case of sensitive biological ingredients, potency has decreased. The problem may not have been the original sample. The problem may have been time. Stability is a dynamic process. An ingredient can meet every specification at the time of release while still being sensitive to environmental conditions during storage. This is why raw material stability should be considered before commercial production, not only after a finished product shows a stability issue. 7 Practical Checks for Raw Material Stability 1. Look Beyond the Initial COA A COA tells you whether a particular batch met defined specifications when it was tested. It does not, by itself, tell you how the material will behave over an extended storage period. When evaluating a new ingredient, look beyond assay and microbiological results. Depending on the ingredient, useful information may include moisture, water activity, particle characteristics, physical appearance, active-marker stability, recommended storage conditions and packaging requirements. The objective is not to collect unnecessary data. It is to identify the quality attributes most likely to change during storage. 2. Ask About Water Activity, Not Just Moisture Moisture content and water activity are related, but they are not the same measurement. Water activity, or aw, describes the availability of water within a material rather than simply the total amount of water present. USP General Chapter <922> explains that some water may be tightly bound, while other water is more available for chemical, biochemical or microbiological processes. This distinction can matter for hygroscopic powders, probiotics, botanical extracts and other moisture-sensitive ingredients. A material may have an acceptable moisture result while still requiring careful control of its water activity and exposure to ambient humidity. For certain products, asking for water activity data can therefore provide useful information that moisture percentage alone cannot. 3. Understand the Recommended Storage Conditions “Store in a cool, dry place” is often not enough information for a meaningful stability assessment. Ask for the actual recommended storage conditions whenever available. Temperature, humidity and light exposure can affect ingredient quality over time. FDA guidance for dietary supplement operations also emphasizes holding components under appropriate temperature, humidity and light conditions to prevent deterioration. For moisture-sensitive ingredients, the difference between controlled storage and repeated exposure to humid air can become significant. Storage conditions should therefore be treated as part of the raw material specification, not as an afterthought. 4. Evaluate the Packaging as Part of the Ingredient The ingredient itself is only one part of the stability equation. Packaging determines how much protection the material has against moisture, oxygen and light during transportation and storage. For example, a moisture-sensitive powder may require a more protective inner liner or sealed barrier packaging than a relatively stable dry ingredient. This is particularly relevant when material is shipped internationally and may experience changes in temperature and humidity during transportation. The right question is not simply: “What packaging do you use?” It is: “Is the packaging appropriate for the ingredient’s known stability risks?” 5. Identify Ingredients That Need More Attention Not every ingredient requires the same level of stability assessment. Some categories deserve closer attention because their quality can be more sensitive to environmental conditions. Examples include: Probiotics and other biological ingredients Hygroscopic amino acids and powders Botanical extracts with defined active markers Ingredients sensitive to oxidation or light Materials with relatively high moisture sensitivity Ingredients whose physical properties affect processing or dosing For biological products in particular, environmental factors can have a significant impact on biological activity. FDA’s stability guidance for biological products notes sensitivity to factors such as temperature, oxidation, light and other environmental stresses. The appropriate evaluation therefore depends on the ingredient rather than following one checklist for every raw material. 6. Consider Stability Under Real Storage Conditions Stability data becomes much more useful when it reflects the conditions the material is actually expected to experience. Formal stability programs commonly evaluate how quality changes over time under defined environmental conditions. ICH Q1A, for example, addresses the role of temperature, humidity, packaging and storage conditions in stability evaluation. The same principle is useful when qualifying nutritional ingredients: What happens to this material under realistic storage conditions? A supplier may not have a complete stability study for every ingredient and every application. That does not automatically make the material unsuitable. But the absence of useful stability information should be recognized as a risk rather than ignored. 7. Connect Raw Material Stability to the Finished Product One important boundary needs to be clear: Raw material stability data does not replace finished-product stability testing. Once an ingredient enters a formulation, its stability can be affected by other ingredients, processing conditions, water activity, pH, packaging, oxygen exposure and the final dosage form. The final product therefore needs its own stability assessment. However, better raw material information can make that assessment more efficient. If you already know that an ingredient is moisture-sensitive, for example, you can consider packaging, manufacturing controls and storage conditions accordingly instead of discovering the issue months later. A Better Question for Ingredient Qualification Instead of asking only: “Does the sample pass?” A stronger qualification process asks: What are the critical quality attributes? Which attributes are likely to change during storage? Is the ingredient moisture-sensitive? What is the water activity? What storage conditions are recommended? What packaging is used? Is there relevant stability information? Are there known sensitivities to heat, humidity, oxygen or light? How might processing affect the ingredient? What additional controls should be considered in the finished product? These questions do not guarantee a successful shelf life. They help identify risks earlier. What a Responsible Ingredient Supplier Should Provide A supplier cannot guarantee the shelf life of your finished product because the final formulation, packaging and manufacturing process are outside the supplier’s control. But a good supplier should make the available raw material information clear enough for your technical and quality teams to make informed decisions. At Esubio, we provide COA, MSDS and product specification documents with shipments and can discuss application-related parameters such as recommended storage conditions, moisture sensitivity and water activity where relevant. Our ingredient portfolio includes probiotics, botanical extracts, amino acids and functional ingredients used in areas such as Longevity & Cellular Health. The goal is not to promise that every ingredient will remain unchanged for 18 months. The goal is simpler: Give R&D and QA teams better information before the stability risk becomes a finished-product problem. A passing sample tells you where the ingredient stands today. Raw material stability helps you think about where it may be tomorrow. References FDA: Dietary Supplement CGMP Compliance Guide USP <922> Water Activity FDA / ICH Q1A(R2) Stability Testing FDA: Q1A(R2) Stability Testing HOT NEWS TALK TO US 请在浏览器中启用JavaScript来完成此表单。请在浏览器中启用JavaScript来完成此表单。NameEmail *Message * Send

BLOGS

HOT NEWS

TALK TO US